利用药物基因组学指导1例房颤合并肾功能不全患者的华法林个体化治疗(5)
[12] Wen MS， Chang KC， Lee TH， et al. Pharmacogenetic dosing of warfarin in the Han-Chinese population a randomized trial[J]. Pharmacogenomics， 2017， 18(3)： 245-253.
[13] Kleinow ME， Garwood CL， Clemente JL， et al. Effect of chronic kidney disease on warfarin management in a pharmacist-managed anticoagulation clinic[J]. J Manag Care Pharm， 2011， 17(7)： 523-530.
[14] Limdi NA， Beasley TM， Baird MF， et al. Kidney function influences warfarin responsiveness and hemorrhagic complications[J]. J Am Soc Nephro， 2009， 20(4)： 912-921.
[15] Penning-van Beest FJ， van Meegen E， Rosendaal FR， et al. Characteristics of anticoagulant therapy and comorbidity related to overanticoagulation[J].ThrombHaemost， 2001， 86(2)： 569-574.
[16] Abdelhafiz AH， Myint MP， Tayek JA， et al. Anemia， hypoalbuminemia， and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation： a secondary analysis[J]. Clin Ther， 2009， 31(7)： 1534-1539.
[17] Brodsky SV， Nadasdy T， Rovin BH， et al. Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate[J]. Kidney Int， 2011， 80(2)： 181-189.
[18] Ng CY， Tan CS， Chin CT， et al. Warfarin related nephropathy： a case report and review of the literature[J/OL]. BMC Nephrol， 2016，17： 15. doi： 10.1186/s12882-016-0228-4., 百拇医药(周美辰 郑萍)
[13] Kleinow ME， Garwood CL， Clemente JL， et al. Effect of chronic kidney disease on warfarin management in a pharmacist-managed anticoagulation clinic[J]. J Manag Care Pharm， 2011， 17(7)： 523-530.
[14] Limdi NA， Beasley TM， Baird MF， et al. Kidney function influences warfarin responsiveness and hemorrhagic complications[J]. J Am Soc Nephro， 2009， 20(4)： 912-921.
[15] Penning-van Beest FJ， van Meegen E， Rosendaal FR， et al. Characteristics of anticoagulant therapy and comorbidity related to overanticoagulation[J].ThrombHaemost， 2001， 86(2)： 569-574.
[16] Abdelhafiz AH， Myint MP， Tayek JA， et al. Anemia， hypoalbuminemia， and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation： a secondary analysis[J]. Clin Ther， 2009， 31(7)： 1534-1539.
[17] Brodsky SV， Nadasdy T， Rovin BH， et al. Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate[J]. Kidney Int， 2011， 80(2)： 181-189.
[18] Ng CY， Tan CS， Chin CT， et al. Warfarin related nephropathy： a case report and review of the literature[J/OL]. BMC Nephrol， 2016，17： 15. doi： 10.1186/s12882-016-0228-4., 百拇医药(周美辰 郑萍)